[go: up one dir, main page]

PL377745A1 - Postać dawkowania alergenu - Google Patents

Postać dawkowania alergenu

Info

Publication number
PL377745A1
PL377745A1 PL377745A PL37774503A PL377745A1 PL 377745 A1 PL377745 A1 PL 377745A1 PL 377745 A PL377745 A PL 377745A PL 37774503 A PL37774503 A PL 37774503A PL 377745 A1 PL377745 A1 PL 377745A1
Authority
PL
Poland
Prior art keywords
dosage form
allergen dosage
allergen
dosage
Prior art date
Application number
PL377745A
Other languages
English (en)
Other versions
PL218350B1 (pl
Inventor
Henrik Hugo Jacobi
Annette Rommelmayer Lundegaard
Christian Gauguin Houghton
Stig Aasmul-Olsen
Lise Lund Maerkedahl
Jan Sondergaard Andersen
Original Assignee
Alk-Abello A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk-Abello A/S filed Critical Alk-Abello A/S
Publication of PL377745A1 publication Critical patent/PL377745A1/pl
Publication of PL218350B1 publication Critical patent/PL218350B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
    • B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Composite Materials (AREA)
  • Mechanical Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PL377745A 2002-11-26 2003-11-26 Produkt farmaceutyczny, pojemnik wielodawkowy, zastosowanie stałej postaci dawkowania i sposób jej wytwarzania oraz zestaw PL218350B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42908602P 2002-11-26 2002-11-26
DKPA200201825 2002-11-26
DKPA200300279 2003-02-24

Publications (2)

Publication Number Publication Date
PL377745A1 true PL377745A1 (pl) 2006-02-20
PL218350B1 PL218350B1 (pl) 2014-11-28

Family

ID=32397517

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377745A PL218350B1 (pl) 2002-11-26 2003-11-26 Produkt farmaceutyczny, pojemnik wielodawkowy, zastosowanie stałej postaci dawkowania i sposób jej wytwarzania oraz zestaw

Country Status (16)

Country Link
US (6) US20040166123A1 (pl)
EP (2) EP2436395B1 (pl)
JP (2) JP5442924B2 (pl)
KR (2) KR101281147B1 (pl)
CN (1) CN101816787A (pl)
AU (3) AU2003280324A1 (pl)
BR (1) BR0316564A (pl)
CA (1) CA2507551A1 (pl)
CO (1) CO5690534A2 (pl)
IL (1) IL168733A (pl)
IS (1) IS7894A (pl)
MX (2) MXPA05005528A (pl)
NO (1) NO20053142L (pl)
NZ (1) NZ540850A (pl)
PL (1) PL218350B1 (pl)
WO (2) WO2004047793A1 (pl)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2116257T3 (da) 2000-08-09 2013-02-04 Alk Abello As Parenterale vaccineformuleringer og anvendelser deraf
US7927600B2 (en) * 2001-03-30 2011-04-19 Emile Loria Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
CA2554337A1 (en) * 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
DE602005011326D1 (de) * 2004-10-19 2009-01-08 Krka Tovarna Zdravil D D Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
DE602005021388D1 (de) * 2004-11-10 2010-07-01 Alk Abello As Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
NZ561040A (en) 2005-03-18 2009-04-30 Cytos Biotechnology Ag Cat allergen fusion proteins and use thereof
US20090155351A1 (en) 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
US20090297564A1 (en) * 2005-11-04 2009-12-03 Domingo Barber Hernandez Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration
DK1814516T3 (da) * 2005-11-04 2013-03-25 Alk Abello As Anvendelse af en flydende allergivaccineformulering til oromucosal indgivelse
CN101361000B (zh) 2005-12-23 2013-04-17 爱尔开-阿贝优公司 用于药用产品溶出试验的方法
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
WO2008152067A1 (en) * 2007-06-12 2008-12-18 Alk-Abelló A/S An allergen dosage form comprising an antihistamine
GB0711683D0 (en) * 2007-06-16 2007-07-25 Enigma Diagnostics Ltd Compositions
EP2187926B1 (en) 2007-09-11 2012-01-25 Københavns Universitet Prevention of diabetes by administration of gliadin
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5588688B2 (ja) 2010-01-28 2014-09-10 日東電工株式会社 フィルム状製剤
WO2011112788A1 (en) * 2010-03-12 2011-09-15 Antigen Laboratories, Inc. Methods of treating allergies with substantially phenol-free carriers
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
EP3305319A1 (en) * 2010-04-30 2018-04-11 Allovate, LLC Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
EP3524259B1 (en) * 2010-04-30 2021-10-13 Allovate, LLC Oral strip for allergic desensitization via the vestibular mucosal surface
EP2575832B1 (en) * 2010-06-03 2017-07-26 ALK-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
BR122021008456B1 (pt) * 2010-06-03 2021-08-03 Alk-Abelló A/S Métodos de fabricação de um extrato de alérgenos de ácaro de pó doméstico
DK3095441T3 (da) * 2010-10-08 2021-01-11 Scherer Technologies Llc R P Hurtigt opløsende doseringsform af en oral vaccine under anvendelse af stivelse
JP5555148B2 (ja) * 2010-12-10 2014-07-23 日東電工株式会社 シート状製剤及びシート状製剤の製造方法
JP5875246B2 (ja) * 2010-12-10 2016-03-02 日東電工株式会社 シート状製剤及びシート状製剤の製造方法
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
JP5952634B2 (ja) * 2011-05-20 2016-07-13 日東電工株式会社 医薬組成物およびその製造方法
US20120294894A1 (en) * 2011-05-20 2012-11-22 Nitto Denko Corporation Pharmaceutical composition and method for producing the same
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5931449B2 (ja) 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
EP2812026A4 (en) 2012-02-07 2016-04-27 Jolla Inst Allergy Immunolog LIQUES GRASS ALLERGENS AND METHOD AND USES OF IMMUNE REACTION MODULATION
US9539334B2 (en) 2012-05-17 2017-01-10 John Hopkins University Orally dissolving thin films containing allergens and methods of making and use
JP2014034530A (ja) * 2012-08-07 2014-02-24 Nitto Denko Corp アレルゲン含有シート状製剤及びその製造方法
JP6306588B2 (ja) 2012-08-21 2018-04-04 サノフィ・バイオテクノロジー Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
CN103215236A (zh) * 2013-01-29 2013-07-24 中国科学院昆明动物研究所 尘螨过敏原Derf8和Derf20及其基因和应用
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
ES2503516B1 (es) * 2013-04-03 2015-09-09 Inmunotek, S.L. Complejo inmunogénico para vacunación y método de obtención
TWI755763B (zh) 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
EA035045B1 (ru) 2013-09-19 2020-04-21 АЛЛОВЕЙТ, ЭлЭлСи Составы зубной пасты для доставки аллергенов в слизистую оболочку полости рта
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
US20170252295A1 (en) 2014-09-17 2017-09-07 Steerlife India Private Limited Effervescent composition and method of making it
JP6861630B2 (ja) 2014-11-14 2021-04-21 サノフィ・バイオテクノロジー Ｉｌ−４ｒアンタゴニストの投与により鼻ポリープを伴う慢性副鼻腔炎を処置する方法
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
KR101878414B1 (ko) * 2016-08-12 2018-07-13 연세대학교 산학협력단 마이크로니들 패치, 이의 제조방법 및 이를 이용한 알레르기 질환 진단방법
CN118141914A (zh) 2016-09-01 2024-06-07 瑞泽恩制药公司 用于通过施用il-4r拮抗剂来预防或治疗变态反应的方法
US10485844B2 (en) 2016-09-22 2019-11-26 Regeneron Pharmaceuticals, Inc. Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
US10359292B2 (en) 2017-04-05 2019-07-23 International Business Machines Corporation Deep learning allergen mapping
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
EP4344706A3 (en) 2017-10-30 2024-05-22 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
EP3829632A4 (en) 2018-07-27 2022-05-04 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods
CN112584831A (zh) * 2018-08-16 2021-03-30 拜奥海芬治疗学有限公司 利鲁唑口腔崩解片用于治疗疾病的用途
WO2020037151A1 (en) * 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
JP7496356B2 (ja) * 2018-11-30 2024-06-06 ジェネンテック， インコーポレイテッド 凍結乾燥薬剤内の夾雑物を同定するためのレーザー誘起破壊分光法
JP2022514645A (ja) 2018-12-20 2022-02-14 アイミューン セラピューティクス，インコーポレイテッド ピーナツ経口免疫療法において投与が欠落した場合の投与スケジュール
WO2020191346A1 (en) 2019-03-21 2020-09-24 Regeneron Pharmaceuticals, Inc. Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy
CN113966229A (zh) 2019-05-10 2022-01-21 爱沐疗法公司 用于改善花生过敏患者的生活质量的方法
EP3999114A1 (en) 2019-07-16 2022-05-25 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
SG11202113310UA (en) 2019-08-05 2021-12-30 Regeneron Pharma Methods for treating atopic dermatitis by administering an il-4r antagonist
EP4010001A1 (en) 2019-08-05 2022-06-15 Regeneron Pharmaceuticals, Inc. Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist
JP7050734B2 (ja) * 2019-09-30 2022-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤
CN114053402A (zh) * 2020-08-03 2022-02-18 格林生物医药科技(天津)有限公司 一种过敏原制剂
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022103635A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN117530926A (zh) * 2022-08-02 2024-02-09 江苏众红生物工程创药研究院有限公司 一种舌下片及其在脱敏治疗药物中的应用
WO2024256749A1 (en) 2023-06-12 2024-12-19 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278877A (en) * 1883-06-05 Ribbon or label holder for hats
US57856A (en) * 1866-09-11 Improvement in cultivators
US346622A (en) * 1886-08-03 Bedstead
US44351A (en) * 1864-09-20 Gang-plow
US271079A (en) * 1883-01-23 Grain weigher and tally
US107208A (en) * 1870-09-06 Improvement in apparatus for the manufacture of illuminating-gas
US2378383A (en) * 1942-10-17 1945-06-19 Brush Dev Co Transient signal recordingreproducing device
US3816314A (en) * 1972-05-31 1974-06-11 Exxon Research Engineering Co Block copolymers of unsaturated ester and a nitrogen containing monomer as v.i.improving and dispersant additives for oils
DD107208A1 (pl) 1973-06-04 1974-07-20
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4371513A (en) * 1977-03-25 1983-02-01 W. R. Grace & Co. Alumina compositions
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US4822611A (en) 1986-12-09 1989-04-18 Immunotec, Inc. Oral hyposensitization in the treatment of allergies
FR2609895B1 (fr) 1987-01-28 1991-06-28 Bruttmann Georges Nouvelles formes galeniques d'allergenes pour administration par voie per- et sub-linguale
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
IT1217628B (it) * 1988-05-18 1990-03-30 Neo Abello Spa Forma farmaceutica e supporto per la somministrazione di estratti ellergenici
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
JPH0537070A (ja) 1991-07-26 1993-02-12 Sharp Corp 分布帰還型半導体レーザ素子の製造方法
JPH0597672A (ja) * 1991-10-08 1993-04-20 Terumo Corp アミド誘導体含有固形製剤およびその製造方法
WO1993019741A1 (en) * 1992-03-31 1993-10-14 Benzon Pharma A/S A pharmaceutical formulation
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5343762A (en) 1992-10-05 1994-09-06 Rosemount Inc. Vortex flowmeter
US5343672A (en) * 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6074673A (en) 1996-04-22 2000-06-13 Guillen; Manuel Slow-release, self-absorbing, drug delivery system
JP2832885B2 (ja) 1996-09-02 1998-12-09 株式会社林原生物化学研究所 スギ花粉アレルゲン
CA2270877C (en) 1996-11-13 2011-08-23 Meiji Milk Products Co., Ltd. Peptide-based immunotherapeutic agent
ATE421318T1 (de) * 1997-02-20 2009-02-15 Massachusetts Inst Technology Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
US20020197321A1 (en) * 1997-10-27 2002-12-26 Harry Seager Solid dispersing vaccine composition for oral delivery
DE69939584D1 (de) 1998-03-16 2008-10-30 Alk Abello As Mutiertes rekombinantes allergen
GB9819484D0 (en) * 1998-09-07 1998-10-28 Univ Bristol Therapeutic agents
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
SE9901857D0 (sv) * 1999-05-21 1999-05-21 Anders Cedergren Karl Fischer reagent
AU4139801A (en) 1999-12-06 2001-06-12 Board Of Trustees Of The University Of Arkansas, The Controlled delivery of antigens
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
US6458968B2 (en) * 2000-06-09 2002-10-01 Rensselaer Polytechnic Institute Dithiocarboxylic ester synthetic process
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
HUP0302601A3 (en) 2000-11-16 2010-01-28 Alk Abello As Mutant allergens
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
GB2378383A (en) 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
DE10137232A1 (de) * 2001-07-30 2003-02-20 Pierre Foss Allergenträger
WO2003096869A2 (en) 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Also Published As

Publication number Publication date
JP2011093926A (ja) 2011-05-12
IS7894A (is) 2005-06-14
KR101281147B1 (ko) 2013-07-02
KR20120034767A (ko) 2012-04-12
US10080719B2 (en) 2018-09-25
MXPA05005528A (es) 2006-04-05
JP5622594B2 (ja) 2014-11-12
JP2006513269A (ja) 2006-04-20
US9408805B2 (en) 2016-08-09
CN101816787A (zh) 2010-09-01
PL218350B1 (pl) 2014-11-28
AU2010200798B2 (en) 2012-11-15
KR20050103187A (ko) 2005-10-27
CO5690534A2 (es) 2006-10-31
EP1567123A2 (en) 2005-08-31
US10471008B2 (en) 2019-11-12
AU2003283207B2 (en) 2009-12-03
US20160324767A1 (en) 2016-11-10
NZ540850A (en) 2008-11-28
MXPA05005527A (es) 2006-04-05
JP5442924B2 (ja) 2014-03-19
WO2004047793A1 (en) 2004-06-10
AU2010200798A1 (en) 2010-03-25
EP2436395B1 (en) 2017-04-26
US9415015B2 (en) 2016-08-16
BR0316564A (pt) 2005-10-04
AU2003283207C1 (en) 2010-07-29
US20040166123A1 (en) 2004-08-26
AU2003283207A1 (en) 2004-06-18
US20080193535A1 (en) 2008-08-14
IL168733A (en) 2011-01-31
EP2436395A3 (en) 2012-06-20
US20080187558A1 (en) 2008-08-07
WO2004047794A3 (en) 2004-09-16
US20140271722A1 (en) 2014-09-18
EP2436395A2 (en) 2012-04-04
US8329196B2 (en) 2012-12-11
AU2003280324A1 (en) 2004-06-18
WO2004047794A2 (en) 2004-06-10
NO20053142L (no) 2005-06-27
US20170367970A1 (en) 2017-12-28
CA2507551A1 (en) 2004-06-10
HK1087008A1 (zh) 2006-10-06

Similar Documents

Publication Publication Date Title
PL377745A1 (pl) Postać dawkowania alergenu
IL166809A0 (en) Pharmaceutical nati-tnf-alpha antibody formulation
IL165841A0 (en) Mchir antagonists
AU2003260760A8 (en) Device
AU2003245720A8 (en) Electroptic device
AU2003238868A8 (en) Software atomization
GB0207438D0 (en) Formulation
HUP0303948A2 (hu) Szájban diszpergálódó szilárd gyógyszerforma
AU2003226487A8 (en) Formulation
GB0202064D0 (en) Device
GB0316889D0 (en) Pharmaceutical agents
AU2003237473A8 (en) Strained-semiconductor-on-insulator device structures
GB0206505D0 (en) Pharmaceutical combination
GB0201520D0 (en) Pharmaceutical uses
PL373409A1 (pl) Kombinacja farmaceutyczna
GB0200485D0 (en) Strap-securing device
AU2003304212A8 (en) Explosive-activated safe-arm device
GB0219146D0 (en) Substances
GB0212963D0 (en) Uni-rod rest
GB0315019D0 (en) Dosage form
GB2385578B (en) Ramp
AU2003238900A8 (en) Pharmaceutical formulation
GB0224680D0 (en) Pharmaceutical
GB0220451D0 (en) Pharmaceutical use
GB0200612D0 (en) Drug testing